Received on 02 March 2022; revised on 05 April 2022; accepted on 07 April 2022
Oculopharyngeal muscular dystrophy (OPMD) is a rare genetic disease that targets the muscles of the eyelids and pharynx. OPMD is caused by an abnormal expansion of a trinucleotide repeat (GCG) in the coding region of poly-A binding protein nuclear 1 gene (PABPN-1). Patients with OPMD present mainly with ptosis, dysphagia, and extremity weakness. Herein, we present a case report of a patient with OPMD. Our case report will provide detailed information regarding the outpatient management of OPMD, as well as possible therapies of the future for these patients.
George Trad, Nazanin Sheikhan, Victoria, Diaz, Eujean Park and Gemil Hatim. Oculopharyngeal muscular dystrophy, rare genetic disorder: A case report. World Journal of Advanced Research and Reviews, 2022, 14(1), 140-143. Article DOI: https://doi.org/10.30574/wjarr.2022.14.1.0300
All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.